SYNBIOTICS CORPORATION EXHIBIT 11.1
------------
COMPUTATION OF EARNINGS PER SHARE
- -------------------------------------------------------------------------------
THREE MONTHS ENDED SIX MONTHS ENDED
JUNE 30, JUNE 30,
----------------------- -----------------------
1996 1995 1996 1995
---------- ---------- ---------- ----------
PRIMARY EARNINGS PER SHARE:
Net income per statement of operations $1,519,000 $ 980,000 $3,169,000 $1,734,000
========== ========== ========== ==========
Weighted average number of shares outstanding 6,028,000 5,806,000 5,968,000 5,805,000
========== ========== ========== ==========
Primary earnings per share $ .25 $ .17 $ .53 $ .30
========== ========== ========== ==========
FULLY DILUTED EARNINGS PER SHARE:
Net income per statement of operations $1,519,000 $ 980,000 $3,169,000 $1,734,000
========== ========== ========== ==========
Reconciliation of weighted average number of
shares per primary computation above, to
amount used for fully diluted computation:
Weighted average number of shares outstanding,
per primary computation 6,028,000 5,806,000 5,968,000 5,805,000
Add-effect of outstanding options (as determined
by the application of the treasury method) 38,000 5,000 26,000 4,000
---------- ---------- ---------- ----------
Weighted average number of shares, as adjusted 6,066,000 5,811,000 5,994,000 5,809,000
========== ========== ========== ==========
Fully diluted earnings per share $ .25 $ .17 $ .53 $ .30
========== ========== ========== ==========
1